Market Tracker

02/23 1:26pm ET

Perrigo Company PLC (NYSE:PRGO)

84.35
BATS BZX Real-Time Price
As of 1:26pm ET
 +0.26 / +0.31%
Today’s Change
71.84
Today|||52-Week Range
140.65
+1.35%
Year-to-Date
How Starboard Hopes to Extract Value From Tribune
Feb 22 / TheStreet.com - Paid Partner Content
13D Management LLC Buys HD Supply Holdings, Perrigo Co PLC, Pandora Media, Sells Cabe...
Feb 16 / GuruFocus News - Paid Partner Content
Why Big Activist Is Targeting Tribune Media
Feb 22 / TheStreet.com - Paid Partner Content
Perrigo Company (PRGO) Q4 Earnings: Disappointment in Store?
Feb 10 / Zacks.com - Paid Partner Content
Bristol-Myers Buys Back Shares, Shuffles Board
Feb 21 / TheStreet.com - Paid Partner Content
US energy stocks retreat as oil price slips
Feb 07 / FT.com - Paid Partner Content
Mivtachim The Workers Social Insurance Fund Ltd. ...
Feb 16 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close84.09
Today’s open83.68
Day’s range83.62 - 84.35
Volume74,983
Average volume (3 months)1,735,870
Market cap$12.1B
Dividend yield0.76%
Data as of 1:26pm ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.40%
Revenue growth (last year)+36.36%
P/E ratio17.7
Price/Sales3.82
Price/Book1.20

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc-3.48-1.83%
SGENSeattle Genetics Inc-1.27-1.97%
BMRNBiomarin Pharmaceuti...-0.10-0.11%
ALKSAlkermes Plc-0.20-0.38%
Data as of 1:24pm ET, 02/23/2017

Financials

Last reporting dateFebruary 23, 2017
EPS forecast (this quarter)$1.62
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John T. Hendrickson
Executive VP, Chief Financial &
Accounting Officer
Judy L. Brown
Corporate headquarters
Dublin, Dublin

Forecasts